Exogenous Ketosis and Muscle Protein Synthesis During Exercise Recovery
The Effects of Ketone Monoester Intake on Postprandial Myofibrillar Protein Synthesis Rates in Young Adults During Recovery Following an Acute Bout of Resistance Exercise
1 other identifier
interventional
48
1 country
1
Brief Summary
An acute bout of resistance exercise stimulates muscle protein synthesis (MPS) rates for up to 24-48 hours, supporting muscle growth and repair. To optimize the anabolic effects of resistance exercise, the provision of dietary amino acids (i.e., proteins) is essential. Dietary protein intake provides the body with necessary amounts of essential and non-essential amino acids, which represent the building blocks for muscle proteins, enhancing anabolic muscle growth. The ingestion of dietary protein, such as whey protein, is well established to stimulate an increase in the rate of protein synthesis in skeletal muscle following resistance exercise. Research has demonstrated a dose-dependent relationship between protein intake and MPS rate, with 25 grams being the optimal dose to maximally stimulate MPS rates in younger adults with excess protein oxidized as a fuel source. Determining whether this maximally stimulated MPS response can be further heightened during post-exercise recovery using non-protein dietary factors is yet to be explored. Recently, it has been shown that novel orally ingested ketone body supplements can stimulate MPS rates in younger adults at rest. Ketone bodies (β-OHB) are lipid- derived molecules normally produced under conditions of glucose deprivation (i.e., fasting/starvation, or a low carbohydrate 'ketogenic' diet). However, these orally ingested ketone supplements rapidly increase blood ketone levels without the need for dietary restriction6. In vitro research showed that the combination of leucine and ketone bodies stimulated a 2-fold increase in MPS, compared to the leucine group alone, indicating synergistic effects of protein and ketone bodies on MPS. However, the effect of ketone supplementation, with and without dietary protein co-ingestion, on MPS rate during post-exercise recovery is yet to be investigated. If ketone bodies can amplify the anabolic response to dietary protein, they may provide a novel approach to maximizing muscle adaptation during post-exercise recovery. Therefore, the purpose of this study is to evaluate the effects of ketone monoester intake on postprandial muscle protein synthesis rates when consumed alone and when co-ingested with an optimal dose (25 g) of whey protein during recovery after resistance exercise compared to 1) an optimal dose of whey protein (25 g), and 2) a control flavored water. It is hypothesized that muscle protein synthesis rates will be stimulated following the ingestion of the ketone body beverage. Further, muscle protein synthesis rates will be further enhanced when the ketone-containing beverage and an optimal dose are taken together.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 6, 2025
CompletedFirst Posted
Study publicly available on registry
January 10, 2025
CompletedStudy Start
First participant enrolled
January 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 2, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 2, 2026
CompletedMarch 23, 2026
March 1, 2026
1.1 years
January 6, 2025
March 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Myofibrillar fractional synthesis rate
Quantification of changes in basal myofibrillar fractional synthetic rate (%/hour) in the rested and exercised limbs.
0 - 5 hours in the postprandial period.
Secondary Outcomes (14)
Time-course data for plasma enrichments (in moles percent excess) of L-[ring-2H5]-phenylalanine
Baseline, 3 hours pre-prandial, and 5 hours into the postprandial period.
Incremental area under the curve for total amino acid concentration
3 hours pre-prandial to 5 hours postprandial
Time-course data for total amino acid concentration
Baseline, 3 hours pre-prandial, and 5 hours into the postprandial period.
Incremental area under the curve for essential amino acid concentration
3 hours pre-prandial to 5 hours postprandial
Time-course data for essential amino acid concentration
Baseline, 3 hours pre-prandial, and 5 hours into the postprandial period.
- +9 more secondary outcomes
Study Arms (4)
Ketone Monoester (KET)
EXPERIMENTALKetone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight).
Ketone Monoester + Whey Protein (KET+PRO)
EXPERIMENTALKetone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight) and 25g of whey protein.
Whey Protein (PRO)
EXPERIMENTAL25g of whey protein.
Placebo drink (CON)
PLACEBO COMPARATORFlavoured water.
Interventions
\- Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight). The ketone brand name: delta G Oxford Ketone Ester
* Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight) * 25g Whey Protein * L-\[ring-2H5\]-phenylalanine tracer (enriched to 4%)
* 25g Whey Protein * L-\[ring-2H5\]-phenylalanine tracer (enriched to 4%)
\- Flavoured water (non-caloric bitter + citrus flavours)
\- 8 sets of 10 reps at 90% of 10- repetition maximum (10-RM) of unilateral leg extension with 90 seconds rest in between sets.
Eligibility Criteria
You may qualify if:
- Healthy adult female or male participants who are 18-40 years of age (inclusive) BMI \>18.5 and \<30.0 kg/m2
- Moderately active (i.e., ≥ 1 session of lower-body weightlifting /week for the previous 2 months).
You may not qualify if:
- Be willing to entirely avoid alcohol consumption 48hr prior to the experimental test day.
- Willing and able to agree to the requirements and restrictions of this study, be willing to give voluntary consent, be able to understand and read the questionnaires, and carry out all study-related procedures.
- Females who are lactating or pregnant
- Females using third-generation oral contraceptives (including: Desogen®, Ortho-Cept, Ortho-Cyclen, Ortho Tri-Cyclen) as these are known to affect protein metabolism in females.
- Individuals with metabolic disorders including: Type I or Type II diabetes
- Individuals with a history of thrombosis / cardiovascular disease
- Individuals who use of anticoagulants
- Individuals with musculoskeletal / orthopedic disorders
- Individuals with knee injuries (i.e., ACL injuries).
- Individuals who have used tobacco products within the last 6 months
- Individuals with a history of neuromuscular problems
- Chronic usage of medications known to modulate skeletal muscle metabolism (i.e. corticosteroids, hormone replacement therapy (HRT), and over-the-counter supplements including creatine monohydrate) in the last 6 months.
- Individuals with allergies to milk proteins (whey or casein).
- Individuals with lactose intolerance
- Individuals with Phenylketonuria (PKU)
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
McGill University
Montreal, Quebec, H2W 1S4, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tyler Churchward-Venne, PhD
Department of Kinesiology and Physical Education, McGill University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants, Investigators and Outcome Accessors will be blinded to the intervention and control drinks. The drinks will be flavor matched and provided in an opaque bottle. An individual not involved with the study data collection, analysis and interpretation will be designated as a study blinder and randomizer.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 6, 2025
First Posted
January 10, 2025
Study Start
January 10, 2025
Primary Completion
March 2, 2026
Study Completion
March 2, 2026
Last Updated
March 23, 2026
Record last verified: 2026-03